Prescribing Practices for Controlled Substances
Hours: 1.00
Healthcare providers face many difficulties when prescribing controlled substances for management of acute and chronic pain, anxiety disorder, and attention deficit hyperactivity disorder (ADHD). The pressure to adequately treat patients suffering from these conditions, coupled with current public health problems such as rising drug overdose rates, creates a major dilemma for healthcare providers. Determining which patients could benefit from the prescription of controlled substances and which patients may suffer adverse consequences by taking these medications is not always easy.
The goal of this course is to educate healthcare providers on methods to safely and responsibly prescribe controlled substances to patients.
Healthcare providers face many difficulties when prescribing controlled substances for management of acute and chronic pain, anxiety disorder, and attention deficit hyperactivity disorder (ADHD). The pressure to adequately treat patients suffering from these conditions, coupled with current public health problems such as rising drug overdose rates, creates a major dilemma for healthcare providers. Determining which patients could benefit from the prescription of controlled substances and which patients may suffer adverse consequences by taking these medications is not always easy. The goal of this course is to educate healthcare providers on methods to safely and responsibly prescribe controlled substances to patients.
District of Columbia Board of Nursing
District of Columbia Board of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Nurses will receive 1.00 contact hours for participating in this course.
Florida Board of Nursing
Florida Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.00 contact hours for participating in this course.
American Nurses Credentialing Center
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses will receive 1.00 Nursing Contact Hours after successfully completing this course.
Georgia Board of Nursing
Georgia Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.00 contact hours for participating in this course.
Accreditation Council for Continuing Medical Education
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Relias LLC designates this enduring activity for a maximum of 1.00 AMA PRA category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
South Carolina Board of Nursing
South Carolina Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.00 contact hours for participating in this course.
Florida Board of Medicine
Florida Board of Medicine (CEBroker Provider #50-290)
Physicians will receive 1.00 AMA PRA category 1 Credits™.
West Virginia Board of Registered Nursing
West Virginia Board of Registered Nursing (CEBroker Provider #50-290)
Nurses will receive 1.00 contact hours for participating in this course.
Accreditation Council for Pharmacy Education
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Type Activity: Knowledge
Target Audience Designation: P
ACPE Universal Activity Number: JA4008266-0000-22-014-H01-P
New Mexico Board of Nursing
New Mexico Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.00 contact hours for participating in this course.
Arkansas State Board of Nursing
Arkansas State Board Of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Nurses will receive 1.00 contact hours for participating in this course.
Ohio State Medical Board
State Medical Board of Ohio (CEBroker Provider #: 50-290)
Physicians will receive 1.00 AMA PRA category 1 Credits™.
Louisiana State Board of Medical Examiners
Louisiana State Board of Medical Examiners (CEBroker Provider #: 50-290)
Physicians will receive 1.00 AMA PRA category 1 Credits™.
Mississippi State Board of Medical Licensure
Mississippi State Board of Medical Licensure (CEBroker Provider #: 50-290)
Physicians will receive 1.00 AMA PRA category 1 Credits™.
Kentucky Board of Nursing
Kentucky Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.00 contact hours for participating in this course.
Mississippi Board of Nursing
Mississippi Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.00 contact hours for participating in this course.
North Dakota Board of Nursing
North Dakota Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.00 contact hours for participating in this course.
New Mexico Medical Board
Physicians will receive 1.00 AMA PRA category 1 Credits™.
South Carolina Board of Medical Examiners
South Carolina Board of Medical Examiners (CEBroker Provider #50-290)
Tennessee Board Of Medical Examiners
Tennessee Board of Medical Examiners (CEBroker Provider #50-290)
Physicians will receive 1.00 AMA PRA category 1 Credits™
Florida Board of Pharmacy
Florida Board of Pharmacy (CEBroker Provider #50-290)
This module is approved for 1.00 contact hours.
Identify strategies for initiating opioid therapy in patients with acute pain, and the relative potency of different class agents.
Recall federal requirements associated with prescribing different schedules of controlled substances for pain management, anxiety disorder, or ADHD.
Describe strategies employed by prescribers to mitigate risks associated with use of controlled substances.
Outline:
Section 1: Introduction
About This Course
Learning Objectives
Section 2: Controlled Substances
History
Controlled Substances Regulation
Definitions of the Different Scheduled Groups (DEA, 2020)
Pain Physiology
Section 3: Treating Conditions with Controlled Substances
Acute Pain Management
Anxiety Disorder
Attention-Deficit Disorder/Attention-Deficit Hyperactivity Disorder
Section 4: Prescribing Controlled Substances
Safe Practices for Prescribing
Section 5: Clinical Vignette
Mrs. Burke’s Story
Section 6: Conclusion
Course Summary
Course Contributors
Resources
References
Doug earned his Doctor of Pharmacy (PharmD) from the Raabe College of Pharmacy at Ohio Northern University in 2011. He completed a PGY-1 residency in Pharmacy Practice at MetroHealth Medical Center in Cleveland, Ohio, and completed a specialty residency in Drug Information and Medical Information at Duke University Hospital and GlaxoSmithKline. He is a board-certified pharmacotherapy specialist, and has worked as a clinical pharmacist within the Center for Medication Policy of the Duke University Health System since 2013. His primary responsibilities include chairing the Pharmaceutical Utilization Management Program and Medication Alert Optimization Committee for the health system. He also serves as an APPE preceptor, PGY-1 residency coordinator, and is a member of the Duke University Health System Institutional Review Board. Disclosure: Doug Raiff, PharmD, BCPS has no Relevant Financial or Non-Financial Relationship with ineligible companies to disclose.Writer: Sooa Devereaux, MSN, RN
Sooa Devereaux, MSN, RN, has a long history of professional development experience within the hospital setting. She has taught in pre-licensure nursing programs and has mentored many nurses, both new graduate and experienced, throughout her career as a nurse educator. Sooa is a Lead SME Writer at Relias and holds an MSN in Nursing Education.
Disclosure: Sooa Devereaux, MSN, RN has no Relevant Financial or Non-Financial Relationship with ineligible companies to disclose.
The target audience for this course is: Nurses; Pharmacists; Physicians; in the following settings: Acute Care Facility.
Asynchronous/Online Distance Learning; please see certificate details for specifics on delivery format.
Relias has a grievance policy in place to facilitate reports of dissatisfaction. Relias will make every effort to resolve each grievance in a mutually satisfactory manner. In order to report a complaint or grievance please contact Relias.
If you require special accommodations to complete this module, please contact Relias Support by completing the web form (https://www.relias.com/help) or by using the chat functionality.
All courses offered by Relias, LLC are developed from a foundation of diversity, inclusiveness, and a multicultural perspective. Knowledge, values and awareness related to cultural competency are infused throughout the course content.
Reference herein to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer or otherwise does not constitute or imply any endorsement, recommendation, or favoring of, or affiliation with, Relias, LLC.
All characteristics and organizations referenced in the following training are fictional. Any resemblance to any actual organizations or persons living or dead, is purely coincidental.
To earn continuing education credit for this course you must achieve a passing score of 80% on the post-test and complete the course evaluation.
If you require special accommodations to complete this module, please contact Relias Customer Support here.
